Researchers have been excited about the medication , a novel dual treatment showing remarkable outcomes in early trials for weight loss . It functions by targeting two pathways : GLP-1 and GIP, these, https://rafaelewcj086681.estate-blog.com/39646684/this-new-possibility-for-weight-management